US 12,070,420 B2
Direct selective laser trabeculoplasty
Zachary Sacks, Modiin (IL)
Assigned to BELKIN VISION LTD., Yavne (IL)
Filed by BELKIN VISION LTD., Yavne (IL)
Filed on May 3, 2022, as Appl. No. 17/735,153.
Application 17/735,153 is a continuation of application No. 17/254,279, previously published as PCT/IB2019/055564, filed on Jul. 1, 2019.
Claims priority of provisional application 62/692,868, filed on Jul. 2, 2018.
Claims priority of provisional application 62/739,238, filed on Sep. 30, 2018.
Claims priority of provisional application 62/748,461, filed on Oct. 21, 2018.
Prior Publication US 2022/0257414 A1, Aug. 18, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61F 9/008 (2006.01); A61B 90/00 (2016.01); A61F 9/007 (2006.01)
CPC A61F 9/008 (2013.01) [A61B 90/04 (2016.02); A61F 9/0079 (2013.01); A61F 9/00823 (2013.01); A61B 2090/049 (2016.02); A61F 2009/00868 (2013.01); A61F 2009/00891 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A system, comprising:
a radiation source;
one or more beam-directing elements; and
a controller, configured to:
cause the radiation source to emit one or more aiming beams at the beam-directing elements such that the aiming beams are directed, by the beam-directing elements, toward an eye of a patient,
verify that each of the aiming beams is properly directed by the beam-directing elements, and
in response to verifying that each of the aiming beams is properly directed by the beam-directing elements, treat the eye by causing the radiation source to irradiate one or more target regions of the eye with respective treatment beams.